[PDF] Top 20 β Blockers: A systematic review

... A β-1- receptor blocker with nitric oxidepotentiating vasodilatory effect used in treatment of hypertension and, in Europe, also for left ventricular failure ... See full document

... cardioselective β-blockers and non-selective β- blockers showed that non-selective β-blockers were as- sociated with lower hospital mortality, adjusted OR for non-selective ... See full document

... Abstract: Background: Beta-blockers are widely used in pregnancy-induced hypertension and heart disease be- cause of their good efficacy. The effects of β-blockers on fetal outcomes are ... See full document

... (eg, β -blockers, angiotensin- converting enzyme inhibitors) can be used to alleviate symp- toms of heart failure and prolong life in boys with Barth ... See full document

... this systematic review following an adap- tion of the standard methodology recommended by the Cochrane collaboration [19] and the PRISMA statement ...for systematic reviews and meta-analysis ... See full document

... Consistent with the above, a recent multicentre study by the North American Consortium for the Study of End-stage Liver Disease (NACSELD) published at the American Association for the Study of Liver Diseases (AASLD) 2015 ... See full document

... In the International Verapamil-Trandolapril Study (INVEST) trial, approximately 23 000 patients with HTN and CHD were randomised to verapamil or atenolol. Verapamil-treated patients had a signi fi cantly lower incidence ... See full document

... [34] in a cross-sectional study of 84 ran- domly selected thalassemia patients reported that visual acuity (VA) was affected in 13 patients and changes in the retinal pigment epithelium [r] ... See full document

... bladder. β-Adrenergic receptor blockers appear to have a beneficial clinical effect in ...we review the evidence of an association between β- adrenergic receptor blockade and ...link β- ... See full document

... tematic review of studies that addressed the PK para- meters of b-lactam antibiotics in ICU patients to assess the relationship between dose and schedule of b-lactam antibiotics and their adequacy according to ... See full document

... of β- Blockers on morbidity and mortality outcomes in Congestive Heart Failure (CHF) ...A systematic search was performed of PubMed, Cochrane library Ovid, Scopus & Google scholar to identify ... See full document

... that β-blockers can decrease tissue oxygen consumption has led several authors to investigate the role of β-blockers in critical illness, which is characterized by increased resting energy ... See full document

... angiotensin-receptor blockers and ...receptor blockers and β blockers, are of proven benefit and are used commonly for management of patients with heart failure and reduced ejection ... See full document

... Topical β-blockers are affordable and widely used to lower intraocular ...topical β-blockers. This review summarizes clinically significant polymorphisms that have been identified in ... See full document

... diuretics, β-blockers, angiotensin converting enzyme inhibitors, angiotensin receptor blockers and calcium channel blockers have all been shown to reduce complications of Hypertension and may ... See full document

... comprehensive review of patient’s prescriptions against pre- determined standards to ensure its appropriateness for better clinical ...receptor blockers (ARBs) along with loop diuretics are important ... See full document

... Exclusion Criteria.—We excluded the following: 1 patients with end-stage re¬ nal disease or those residing outside New Jersey; 2 those hospitalized with an AMI in the 12 months preceding[r] ... See full document

... rates among the study groups (P = 0.357). NT pro-BNP levels were significantly higher in those patients who died than those who survived (195.7 pg/mL [range 70.5–449.3] versus 707.1 pg/mL [range 194.9–2,393.1], P  ... See full document

... fully a third (33%) was on less than 5 mg. In COPERNICUS carvedilol was initiated at 3.125 mg bd for 2 weeks, progressing every 2 weeks to 6.25 mg bd, then 12.5 mg bd before seeking the target dose of 25 mg bd. Mean ... See full document

... Readmissions were measured in eleven reviews, but the measurement period was frequently 6 or 12 months and not the 3 months that is of interest for this meta-review. Seven reviewers [79,95,97,100,102,103,105] are ... See full document